"Propylamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
| Descriptor ID |
D011437
|
| MeSH Number(s) |
D02.092.831
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propylamines".
Below are MeSH descriptors whose meaning is more specific than "Propylamines".
This graph shows the total number of publications written about "Propylamines" by people in this website by year, and whether "Propylamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propylamines" by people in Profiles.
-
Wang Z, Zuschlag ZD, Myers US, Hamner M. Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study. Depress Anxiety. 2022 04; 39(4):286-295.
-
McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, White KG, Brady KT. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
-
Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008 Jul 01; 96(1-2):145-54.
-
Reichel CM, Linkugel JD, Bevins RA. Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications. Exp Clin Psychopharmacol. 2007 Oct; 15(5):501-9.
-
Barkley RA, Anderson DL, Kruesi M. A pilot study of the effects of atomoxetine on driving performance in adults with ADHD. J Atten Disord. 2007 Feb; 10(3):306-16.
-
Garside D, Ropero-Miller JD, Riemer EC. Postmortem tissue distribution of atomoxetine following fatal and nonfatal doses--three case reports. J Forensic Sci. 2006 Jan; 51(1):179-82.
-
Christman AK, Fermo JD, Markowitz JS. Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy. 2004 Aug; 24(8):1020-36.
-
Ross SA, Weete JD, Schinazi RF, Wirtz SS, Tharnish P, Scheuer PJ, Hamann MT. Mololipids, a new series of anti-HIV bromotyramine-derived compounds from a sponge of the order verongida. J Nat Prod. 2000 Apr; 63(4):501-3.
-
McCloskey DE, Woster PM, Casero RA, Davidson NE. Effects of the polyamine analogues N1-ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-ethylN-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells. Clin Cancer Res. 2000 Jan; 6(1):17-23.
-
Turner SM, Jacob RG, Beidel DC, Griffin S. A second case of mania associated with fluoxetine. Am J Psychiatry. 1985 Feb; 142(2):274-5.